Rhomboid Intercostal and Subserratus Plane Block

NCT04085263 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2022-09-13

No results posted yet for this study

Summary

This clinical trial will be conducted at Tanta University Hospitals, General Surgery Hospitals on female patients undergoing radical mastectomy

. All the patients will receive general anesthesia.

The patients will be randomly allocated into one of the following two groups;- - Control group (30 patients): The patients in this group will receive sham rhomboid intercostal and subserratus plane.

\- Rhomboid intercostal and subserratus plane block group (30 patients): The patients in this group will be receive real ultrasound-guided rhomboid intercostal and subserratus plane.

The primary outcome measure will be the total dose of morphine consumed in the first 24 h after surgery and the secondary outcome will be the postoperative pain score.

Conditions

  • Postoperative Pain
  • Regional Anesthesia Morbidity

Interventions

PROCEDURE

Control group

The patients in this group will receive sham rhomboid intercostal and subserratus plane.

PROCEDURE

Rhomboid intercostal and subserratus plane block group

The patients in this group will be receive real ultrasound-guided rhomboid intercostal and subserratus plane.

Sponsors & Collaborators

  • Dr. Mohamed shebl Abdelghany

    collaborator UNKNOWN
  • Tanta University

    lead OTHER

Principal Investigators

  • Sameh Ismaiel, M.D · Lecturer of Anesthesia and Intensive Care, Tanta University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2022-09-06
Completion
2022-09-06

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04085263 on ClinicalTrials.gov